PTGS2 and colitis: While genistein [20], soyasaponin [42,44], and lunasin [104] have been shown to markedly attenuate colitis-induced increases in colonic COX-2 mRNA, additional studies are needed to determine potential differences in effect in terms of timing of treatment administration.